Search

Author/Creator Vaddady, Pavan

2. No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy. Issue 6 (24th July 2018)

Authors:
Feng, Hwa‐Ping; Guo, Zifang; Caro, Luzelena; Marshall, William L.; Liu, Fang; Panebianco, Deborah; Vaddady, Pavan; Reitmann, Christina; Jumes, Patricia; Wolford, Dennis; Fraser, Iain; Valesky, Robert; Martinho, Monika; Butterton, Joan R.; Iwamoto, Marian; Webster, Lynn; Yeh, Wendy W.
Journal:
Clinical and translational science
Issue:
Volume 11:Issue 6(2018)
Page Start:
553
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy. Issue 6 (24th July 2018)

Authors:
Feng, Hwa‐Ping; Guo, Zifang; Caro, Luzelena; Marshall, William L.; Liu, Fang; Panebianco, Deborah; Vaddady, Pavan; Barbour, April; Reitmann, Christina; Jumes, Patricia; Gilmartin, Jocelyn; Wolford, Dennis; Valesky, Robert; Martinho, Monika; Butterton, Joan R.; Iwamoto, Marian; Fraser, Iain; Webst...
Journal:
Clinical and translational science
Issue:
Volume 11:Issue 6(2018)
Page Start:
562
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 1159. Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Pediatric Participants With Confirmed or Suspected Gram-negative Bacterial Infections: A Phase 1b, Open-label, Single-Dose Clinical Trial. (4th December 2021)

Authors:
Bradley, John S; Makieieva, Nataliia; Tøndel, Camilla; Roilides, Emmanuel; Kelly, Matthew S; Patel, Munjal; Vaddady, Pavan; Maniar, Alok; Zhang, Ying; Paschke, Amanda; Butterton, Joan R; Chen, Luke F
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S671
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 1159. Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Pediatric Participants With Confirmed or Suspected Gram-negative Bacterial Infections: A Phase 1b, Open-label, Single-Dose Clinical Trial. (4th December 2021)

Authors:
Bradley, John S; Makieieva, Nataliia; Tøndel, Camilla; Roilides, Emmanuel; Kelly, Matthew S; Patel, Munjal; Vaddady, Pavan; Maniar, Alok; Zhang, Ying; Paschke, Amanda; Butterton, Joan R; Chen, Luke F
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S671
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A Randomized, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Insulin Dimer. Issue 1 (3rd May 2022)

Authors:
Walford, Geoffrey A.; Duncan, Kelly E.; Hernandez, Moises; Vaddady, Pavan; Hompesch, Marcus; Morrow, Linda; Stoch, S. Aubrey
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 112:Issue 1(2022)
Page Start:
125
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗